期刊文献+

下咽鳞癌患者血清比较蛋白质组学研究 被引量:6

Serum comparative proteomic analysis of hypopharyngeal squamous cell carcinoma
原文传递
导出
摘要 目的 从蛋白质组学角度探讨下咽癌血清蛋白质组指纹图谱.方法 采集58例下咽癌患者和41正常对照者血清,应用CM10芯片和PBSⅡ-C型蛋白质芯片阅读机检测,对下咽癌组和正常组及下咽癌组内不同亚组间的血清蛋白质指纹图谱比较,寻找相关差异蛋白,初步建立分类树诊断模型和放疗敏感性预测模型.结果 下咽癌组与正常对照组间有9个差异蛋白质峰(P〈0.05);建立的下咽癌决策分类树诊断模型诊断符合率为90.10%;下咽癌颈淋巴结转移组和无转移组差异无统计学意义(P〉0.05);分化较差组和分化较好组有1个蛋白差异有统计学意义(P〈0.05);化疗敏感组和不敏感组差异无统计学意义(P〉0.05);放疗敏感组和不敏感组比较,P≤0.05时有5个差异蛋白峰,均在放疗敏感组高表达.Biomarker Pattern软件建立的下咽癌放疗敏感性分类树预测模型,灵敏度100.00%,特异度83.33%.结论 下咽癌和正常对照比较血清中存在特异性的差异表达蛋白,下咽癌放疗敏感组患者血清中m/z为6115.75的蛋白较放疗不敏感组高表达(P〈0.01). Objective To detect the serum proteomic patterns in hypopharyngeal squamous cell carcinoma (HPSCC) patients. Methods The study included 58 HPSCC patients and 41 normal controls. The serum samples were analyzed for protein expression using by SELDI-TOF-MS protein chip array technology and cation-exchange (CM10) Protein array. Results There were 9 peaks differentially expressed between HPSCC patients and normal controls (P〈0. 05). Using tree analysis pattern, the combination of these biomarkers could discriminate HPSCC from normal controls with a total accuracy of 90. 10%. There was no statistically significant difference in serum proteins between HPSCC patients with and without cervical lympha node metastasis ( P 〉 0.05 ) , and the difference between well-differentiated and poorly-differentiated cancer was quite minor. There was no any statistically significant difference between chemotherapy sensitive patients and nonsensitive patients (P〉0. 05) , but 5 kinds of differentially expressed protein between radiotherapy sensitive patients and nonsensitive patients (P≤0. 05). The radiotherapy sensitive patients were segregated from nonsensitive patients with a sensitivity of 100. 00% and specificity of 83. 33%. Conclusion There are 4 peaks differentially expressed between HPSCC patients and normal controls ( P 〈 0.01). The serum protein at the m/z value of 6115. 74 of HPSCC radiotherapy sensitive patients is expressed higher than radiotherapy nonsensitive patients (P〈0.01).
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第6期829-831,共3页 Chinese Journal of Experimental Surgery
关键词 下咽肿瘤 鳞状细胞癌 蛋白质组 放疗 Hypopharyngeal neoplasm Squamous cell carcinoma Proteomics Radiotherapy
  • 相关文献

参考文献9

  • 1Gourin CG,Terris DJ.Carcinoma of the hypopharynx.Surg Oncol Clin N Am,2004,13:81-98.
  • 2徐韬,胡伟汉,伍国号,郭朱明,高远红,王芳,蔡修宇.151例下咽鳞癌的治疗方式与预后[J].中国肿瘤临床,2008,35(11):606-610. 被引量:7
  • 3Lee KJ.Essential otolaryngology:head and neck surgery,Ninth Edition.New York:Mcgraw-hill Professional Publishing,2008:676-707.
  • 4李炜,刘炳亚,李建芳,陈雪华,李琦,蔡劬,顾琴龙,朱正纲,林言箴.蛋白质组技术在胃癌相关标志物筛查中的应用[J].中华实验外科杂志,2006,23(10):1210-1212. 被引量:14
  • 5邱继刚,樊嘉,刘银坤,周俭,代智,黄成.肝癌门静脉癌栓相关小分子的比较蛋白质组学分析[J].中华实验外科杂志,2009,26(2):181-183. 被引量:8
  • 6崔冀,汪建平,向军,蔡世荣,骆衍新,黎明涛.结肠腺癌与腺瘤的蛋白质组表达差异[J].中华实验外科杂志,2008,25(6):764-766. 被引量:3
  • 7Gourin CG,Xia ZS,Han Y,et al.Serum protein profile analysis in patients with head and neck squamous cell carcinoma.Arch Otolaryngol Head Neck Surg,2006,132:390-397.
  • 8Gourin CG,Moretz WH,Weinberger PM,et al.Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma.Arch Otohryngol Head Neck Surg,2007,133:1125-1130.
  • 9Zhou L,Cheng L,Tao L,et al.Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.Acta Otolaryngol,2006,126:853-860.

二级参考文献43

共引文献27

同被引文献39

  • 1王秀梅,杰恩斯,马彦清,陈波,郭小进,阿力木太,哈那提,李锋,杨磊,秦江梅.新疆哈萨克族食管癌危险因素病例对照研究[J].中国公共卫生,2007,23(6):737-738. 被引量:33
  • 2王进峰(综述),华立新(审校).肾肿瘤的流行病学研究[J].国际泌尿系统杂志,2007,27(5):632-639. 被引量:6
  • 3Chua KY. Huangfu T, Liew LN. DNA vaccines and allergic diseases. Clin Exp Phamaco Physio1,2006 ,33 :546-550.
  • 4Takano M, Kikuchi Y, Asakawa T, et al. Identification of potential serm markers for endometrial cancer using protein expression profi- ling. J Cancer Res Clin Oncol,2010,136:475-481.
  • 5De Bock M, de Seny D, Meuwis MA, et al. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol, 2010,2010:906082.
  • 6Gomes-AIves P, Imrie M, Gray RD, et al. SELDI-TOF biomarker sig- natures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. Clin Biochem ,2010,43 : 168-177.
  • 7Cho WC, Yip Tr, Yip C, et al. Identification of serm amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res, 2004,10 : 43- 52.
  • 8Keereweer S,Kerrebijn JD,A1-Mamgani A,et al.Chemoradiation for advanced hypopharyngeal carcinoma:a retrospective study on efficacy,morbidity and quality of life[J].Eur Arch Otorhinolaryngol,2012,269(3):939-46.
  • 9Nishimura H,Sasaki R,Yoshida K,et al.Radiotherapy for stage Ⅰ or Ⅱ hypopharyngeal carcinoma[J].J Radiat Res (Tokyo),2012,53(6):892-9.
  • 10Chedid HM,Franzi SA,Rapoport A,et al.Impact of combination therapy on disease free survival in hypopharynx cancer[J].Rev Col Bras Cir,2010,37(6):385-9.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部